|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits with banks | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Securities available-for-sale, at fair value (amortized cost: $1,683,844 2022; $1,741,153; allowance for credit losses: $0) | ||||||||||||||||||||
| Securities held to maturity, net of allowance for credit losses of $0 (fair value: $358,395 - 2022; $0 - 2021) | ||||||||||||||||||||
| Securities available-for-sale, at fair value (amortized cost: $1,119,034 in 2024; $1,164,227 in 2023; allowance for credit losses: $0 in both 2024 and 2023) | ||||||||||||||||||||
| Securities held to maturity, net of allowance for credit losses of $0 (fair value: $537,275 in 2024; $615,944 in 2023) | ||||||||||||||||||||
| Equity securities | ||||||||||||||||||||
| Other securities | ||||||||||||||||||||
| Total securities | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Net loans held for investment | ||||||||||||||||||||
| Loans held for investment | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| LHFI, net of allowance for credit losses of $56,205 in 2024 and $54,032 in 2023 | ||||||||||||||||||||
| Interest receivable | ||||||||||||||||||||
| Premises and equipment | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Finance lease right-of-use assets | ||||||||||||||||||||
| Cash surrender value of life insurance | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangibles | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Non-interest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Interest payable | ||||||||||||||||||||
| Borrowed funds | ||||||||||||||||||||
| Subordinated debentures | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Finance lease liabilities | ||||||||||||||||||||
| Allowance for credit losses on OBSC exposures | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ Equity: | ||||||||||||||||||||
| Common stock, par value $1 per share: 80,000,000 shares authorized; 32,409,962 shares issued in 2024, 80,000,000 shares authorized, and 32,338,983 shares issued in 2023, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||||||||||||
| Treasury stock, at cost, 1,249,607 shares at June 30, 2024 and at December 31, 2023 | ||||||||||||||||||||
| Treasury stock, at cost (1,249,607 shares - 2024; 1,249,607 shares - 2023) | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
| Treasury stock (in shares) | ||||||||||||||||||||
Loading...
